Form 4: Shuttle Pharmaceuticals Holdings, Inc. Insider Trading Activity

HRT FINANCIAL LP reports significant transactions in Shuttle Pharmaceuticals Holdings, Inc. common stock.

Summary

• HRT FINANCIAL LP, a 10% owner and director of Shuttle Pharmaceuticals Holdings, Inc., has reported several transactions involving the company's common stock.
• On July 7, 2026, 10,580 shares were acquired at a price of $3.33 per share, resulting in direct beneficial ownership of 70,805 shares.
• On July 8, 2026, an additional 18,531 shares were acquired at a price of $3.52 per share, reducing the directly beneficially owned shares to 52,274.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as an insider is acquiring shares, but the net decrease in holdings is a point of observation.

Positives

• HRT FINANCIAL LP, a significant stakeholder, continues to acquire shares in Shuttle Pharmaceuticals Holdings, Inc., indicating confidence in the company's prospects.
• The acquisitions were made at prices below $4.00, potentially representing a favorable entry point for the reporting person.

Negatives

• The reporting person has reduced their total beneficial ownership of common stock from 70,805 to 52,274 shares between July 7 and July 8, 2026, due to the second transaction being an acquisition of a smaller number of shares than the initial acquisition.

Future Outlook

No specific forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that Form 4 filings are crucial for understanding insider sentiment. Significant acquisitions by 10% owners and directors can signal confidence, but the net reduction in shares held warrants attention.

Stakeholder Impact

• Shareholders may interpret the acquisitions as a positive signal of insider confidence, but the net reduction in shares held by HRT FINANCIAL LP could also be viewed with caution.

Key Dates

Recommendation

The filing indicates insider buying activity, which is generally positive. However, the net reduction in shares held by a significant owner and director, coupled with the lack of other strategic or financial information, suggests a 'hold' position until further developments provide a clearer picture of the company's trajectory.

Keywords

SEC Form 4, Insider Trading, Shuttle Pharmaceuticals Holdings, SHPH, HRT FINANCIAL LP, Beneficial Ownership, Common Stock